DEF: H.B. Fuller Sets 2026 Annual Meeting, Details 2025 Performance
Proxy Statement
H.B. Fuller Company announces its 2026 Annual Meeting of Shareholders, while highlighting strong fiscal 2025 financial results including record adjusted EBITDA margin and a 56th consecutive dividend increase.
Summary
- The 2026 Annual Meeting of Shareholders will be held virtually on Thursday, April 16, 2026, at 10:00 a.m. Central Time.
- Shareholders will vote on the election of three Class III directors, the ratification of Ernst & Young LLP as the independent registered public accounting firm for fiscal year 2026, and a non-binding advisory vote on executive compensation.
- For fiscal year 2025, the company reported Net revenue of $3.47 billion, Net income of $152 million, and EPS of $2.75 (Adjusted EPS of $4.24).
- Adjusted EBITDA reached $621 million, with a record high Adjusted EBITDA Margin of 17.9%.
- Operating cash flow for fiscal 2025 was $263 million.
- The company increased its quarterly cash dividends paid to shareholders by 5.6%, marking the 56th consecutive year of increases.
- Executive compensation payouts for the CEO, CFO, and EVP, Business Transformation were 99% of target, while other Named Executive Officers (NEOs) ranged from 80% to 88% of target.
- Performance-based stock units (PSUs) granted in fiscal year 2023, with a performance measurement period of fiscal years 2023-2025, vested at 80% of target due to an actual Return on Invested Capital (ROIC) of 9.5% against a target of 10.3%.
Sentiment
Score: 7
Explanation: StockSavvy.ai views this as a positive filing, reflecting strong operational execution and profitability growth in a challenging environment, coupled with consistent shareholder returns through dividends. The slight miss on the ROIC target for PSUs and mixed segment performance dips are minor concerns against overall positive trends.
Positives
- Achieved a fiscal year record high Adjusted EBITDA Margin of 17.9% in 2025.
- Delivered growth in adjusted EBITDA and adjusted EPS in fiscal year 2025 despite an unpredictable economic backdrop and challenging demand landscape.
- Successfully implemented a 5.6% increase in quarterly cash dividends, marking the 56th consecutive year of increases.
- Continued strategic transformation into a higher-growth, higher-margin business by investing in specialized market segments.
- The Engineering Adhesives segment showed strong growth, with revenue increasing by 5.2% to $1,062 million and Adjusted EBITDA increasing by 18% to $236 million.
- Executive compensation program received strong shareholder support, with 97% of votes cast for approval in both fiscal 2025 and the prior year.
Negatives
- The Hygiene, Health and Consumable Adhesives segment experienced a 1% decrease in Adjusted EBITDA to $244 million, despite a 0.3% increase in segment revenue.
- The Building Adhesive Solutions segment's Adjusted EBITDA increased by only 1% to $134 million, with segment revenue increasing by 0.4%.
- Actual ROIC for the three-year period of fiscal years 2023-2025 was 9.5%, falling short of the 10.3% target, resulting in PSUs vesting at 80% of target.
- Company-wide Adjusted Net Revenue of $3.438 billion was slightly below the STIP target of $3.500 billion, achieving 98.2% of target.
Risks
- The company operates amidst an unpredictable economic backdrop and challenging demand landscape.
- Exposure to various enterprise risks including financial, operational, strategy, and compliance/regulatory risks.
- Cybersecurity risks are monitored by the Audit Committee.
- Compliance with legal and regulatory requirements, including climate-related reporting, poses ongoing challenges.
- Compensation policies and practices are assessed to ensure they do not create risks reasonably likely to have a material adverse effect on the company.
- Potential for executive misconduct could trigger clawback provisions for incentive compensation.
Future Outlook
The company aims to continue its strategic transformation into a higher-growth, higher-margin business by investing in specialized market segments and divesting from less profitable operations. Short-term incentive plan targets are aligned with the company's long-term strategic financial goals, indicating a continued focus on organic growth, margin enhancement, operational optimization, and efficient capital deployment.
Management Comments
- "Throughout 2025, we demonstrated execution and agility amidst an unpredictable economic backdrop and challenging demand landscape."
- "We helped our customers navigate this environment successfully, providing them with material optionality and flexibility while ensuring consistent quality and reliable availability wherever in the world they chose to make their products."
- "These efforts, which strengthened our partnerships and enhanced the Company’s competitive positioning, are reflected in our improved profitability and sustained margin expansion."
- "We also continued to transform the Company into a higher-growth, higher-margin business by investing in higher margin, faster-growing market segments while selecting out of business that didn’t meet our growth or profit criteria."
Industry Context
StockSavvy.ai notes that H.B. Fuller operates within the specialty chemicals industry, which faced an unpredictable economic backdrop and challenging demand landscape in 2025. The company's strategic focus on higher-growth, higher-margin segments and effective pricing strategies aligns with broader industry trends towards value-added solutions and operational efficiency in a competitive environment. The company's peer group for compensation analysis includes other chemical and materials science firms, indicating a competitive landscape for talent and market positioning.
Comparison to Industry Standards
- The company's compensation peer group, used to inform fiscal 2025 target compensation, consisted of 19 comparable, publicly traded companies with revenues between $1.5 billion and $11.5 billion and a median revenue of $3.9 billion, including Albemarle Corporation, FMC Corporation, Aptar Group Inc., Graco Inc., Avery Dennison Corporation, Hexcel Corporation, Avient Corporation, International Flavors & Fragrances Inc., Axalta Coating Systems Ltd., Nordson Corporation, Cabot Corporation, Olin Corporation, Celanese Corporation, Quaker Chemical Corporation, Donaldson Company, Inc., RPM International Inc., Eastman Chemical Company, and Element Solutions Inc.
- The company generally aligns with the market median/50th percentile for base salary, short-term incentive target values, and long-term incentive target values within its peer group.
- The peer group for cumulative Total Shareholder Return (TSR) comparison is the Dow Jones U.S. Specialty Chemicals Index.
- The modification of the ROIC payment schedule for Performance-based Stock Units (PSUs) to adjust the superior performance level from target plus 4% to target plus 2% was implemented to better align with prevailing market practice and reflect challenging but achievable performance targets.
Management Changes
| Role | Previous Person | New Person | Effective Date | Reason |
|---|---|---|---|---|
| EVP, Business Transformation | NA | Nathan D. Weaver | December 2, 2024 | Promotion |
| Director | Lee R. Mitau | NA | January 23, 2025 | Retirement |
| Independent Chair of the Board | NA | Teresa J. Rasmussen | January 2025 | Appointment |
| Director | NA | Celine C. Martin | December 1, 2025 | Appointment by the Board of Directors |
| CEO of Fastenal Company (external role) | Daniel L. Florness | NA | July 16, 2026 | Decision to step out of role (Mr. Florness remains a director of H.B. Fuller) |
Corporate Governance
| Change Type | Description | Effective Date | Impact Assessment |
|---|---|---|---|
| Director Independence | All Board members, other than the CEO Ms. Mastin, have been determined to be independent. | NA | Ensures strong independent oversight of management and adherence to NYSE listing standards. |
| Board Leadership Structure | The roles of Chair of the Board and Chief Executive Officer have been separated since 2007, with Teresa J. Rasmussen serving as independent Chair since January 2025. | January 2025 | Promotes independent Board oversight, capitalizes on existing Board expertise, and provides an effective allocation of duties. |
| Director Election Standard | Adopted a plurality-plus standard for director elections, requiring a resignation offer if votes withheld exceed votes for election in uncontested elections. | NA | Enhances accountability of directors to shareholders, providing a mechanism for shareholder feedback on individual director performance. |
| Board Performance Evaluation | The Board annually reviews its performance, as well as the performance of its committees and individual directors. | NA | Fosters continuous improvement and effectiveness of the Board and its governance practices. |
| Code of Business Conduct | A Code of Business Conduct is applicable to all directors and employees, including executive officers. | NA | Establishes ethical standards and promotes a culture of integrity across the organization. |
| Insider Trading Policy | Prohibits hedging, pledging, and certain other transactions in company securities by directors and executive officers. | NA | Prevents conflicts of interest and aligns the financial interests of insiders with long-term shareholder value. |
| Compensation Recovery Policy (Clawbacks) | Requires recoupment of incentive-based compensation from current or former executive officers or key managers if payments were based on financial results later subject to restatement due to material non-compliance, or due to intentional misconduct. | NA | Strengthens accountability for financial reporting accuracy and ethical conduct, protecting shareholder interests. |
| PSU Performance Metric Adjustment | The ROIC payment schedule for PSUs was modified to adjust the superior performance level from target plus 4% to target plus 2%, and the treatment of acquisitions in the ROIC formula was streamlined. | Fiscal Year 2025 | Better aligns with prevailing market practice and reflects challenging but achievable performance targets, while simplifying calculation. |
Related Party Transactions
- Customer-supplier transactions occurred between the Company and Fastenal Company, where Daniel L. Florness serves as Chief Executive Officer.
- Customer-supplier transactions occurred between the Company and Cargill, Incorporated, where Ruth S. Kimmelshue was Corporate Senior Vice President, Business Operations & Supply Chain during fiscal 2025.
- Customer-supplier transactions occurred between the Company and Winnebago Industries, Inc., where Michael J. Happe serves as Chief Executive Officer.
- Customer-supplier transactions occurred between the Company and A. O. Smith Corporation, where Charles T. Lauber serves as Executive Vice President and Chief Financial Officer.
- Customer-supplier transactions occurred between the Company and Johnson & Johnson, where Celine C. Martin was Company Group Chairman, Cardiovascular & Specialty Solutions (CSS) Group during fiscal 2025.
- Charitable contributions were made to, and services provided by, the University of Minnesota and its Carlson School of Management, where Srilata A. Zaheer is employed.
- All reviewed transactions were determined by the Audit Committee to be in the ordinary course of business, and the affiliated directors had no direct or indirect material interest in them.
Stakeholder Impact
- Shareholders benefit from consistent dividend increases (56th consecutive year), strong profitability metrics (record Adjusted EBITDA Margin), and an executive compensation program designed to align with long-term value creation.
- Employees are provided with competitive compensation programs, including 401(k) plans and non-elective retirement contributions, and executives receive additional benefits like health exams and financial counseling.
- Customers benefit from the company's focus on providing material optionality, flexibility, consistent quality, and reliable availability, which strengthens partnerships.
- Communities are positively impacted by the company's commitment to social responsibility, minimizing environmental footprint, and corporate giving and employee volunteerism initiatives.
Next Steps
- Shareholders will vote on the election of three Class III directors at the 2026 Annual Meeting.
- Shareholders will vote on the ratification of Ernst & Young LLP as the independent auditor for fiscal year 2026.
- Shareholders will cast a non-binding advisory vote on executive compensation.
- The Board will consider the result of the Say on Pay vote when determining future executive compensation arrangements.
- The Audit Committee intends to reconsider the appointment of Ernst & Young LLP if shareholders do not ratify it.
- Daniel L. Florness will step out of his CEO role at Fastenal Company effective July 16, 2026, though he will continue to serve as a director for H.B. Fuller.
Key Dates
| Date | Description |
|---|---|
| 2020-11-27 | Beginning of the measurement period for Cumulative Total Shareholder Return (TSR). |
| 2021-04-08 | The H.B. Fuller Company 2020 Master Incentive Plan was amended and restated. |
| 2021-11-29 | Fiscal year ended. |
| 2022-11-28 | Fiscal year ended. |
| 2022-12-01 | Celeste B. Mastin became Executive Vice President and Chief Operating Officer. |
| 2023-04-06 | The H.B. Fuller Company 2020 Master Incentive Plan was amended and restated. |
| 2023-11-30 | Fiscal year ended. |
| 2024-12-02 | Nathan D. Weaver was promoted to Executive Vice President, Business Transformation. |
| 2025-01-23 | Lee R. Mitau retired from the Board. Teresa J. Rasmussen was appointed to the Compensation Committee. |
| 2025-01 | The Compensation Committee approved a transaction incentive payment for M. Shahbaz Malik in connection with the sale of the flooring business. |
| 2025-04-15 | Annual Meeting of Shareholders held. The H.B. Fuller Company 2020 Master Incentive Plan was amended and restated. |
| 2025-07-16 | The Compensation Committee made an annual equity award to each non-employee director. Daniel L. Florness notified Fastenal's board of his decision to step out of his CEO role effective July 16, 2026. |
| 2025-09-30 | Date used for global employee count to identify the median employee for CEO pay ratio disclosure. |
| 2025-10 | Celine C. Martin was appointed by the Board of Directors. |
| 2025-11-29 | Fiscal year ended. |
| 2025-12-01 | Celine C. Martin's appointment to the Board became effective. |
| 2025-12 | The Board considered Daniel L. Florness's resignation from the Board in connection with his change in principal employment. |
| 2026-01-31 | Date of Board composition for diversity reporting. |
| 2026-02-18 | Record Date for the 2026 Annual Meeting of Shareholders. |
| 2026-03-04 | Proxy Statement and 2025 Annual Report to Shareholders were first made available. |
| 2026-04-16 | 2026 Annual Meeting of Shareholders to be held. |
| 2026-11-28 | Fiscal year ending for which Ernst & Young LLP is appointed as independent auditor. |
| 2026-12-17 | Earliest date for shareholders to submit proposals for the 2027 Annual Meeting. |
| 2027-01-16 | Latest date for shareholders to submit proposals for the 2027 Annual Meeting. |
| 2027 | Term of office for Class I directors (Thomas W. Handley, Ruth S. Kimmelshue, Srilata A. Zaheer) will expire at the Annual Meeting. |
| 2028 | Term of office for Class II directors (Michael J. Happe, Charles T. Lauber, Celeste B. Mastin) will expire at the Annual Meeting. |
| 2029 | Term of office for Class III directors (Daniel L. Florness, Celine C. Martin, Teresa J. Rasmussen) will expire at the Annual Meeting. |
Recommendation
holdH.B. Fuller demonstrated strong operational performance in fiscal 2025, achieving a record adjusted EBITDA margin and continuing its long streak of dividend increases, which signals financial stability and a commitment to shareholder returns. However, the slight miss on the 3-year ROIC target for PSUs and mixed segment growth indicate areas for continued focus. The company's strategic transformation efforts are positive, but the overall performance suggests a 'hold' as the market likely already prices in these consistent, but not exceptionally accelerating, results. Investors should monitor the execution of the higher-growth, higher-margin strategy and its impact on future ROIC and revenue growth.
Keywords
H.B. Fuller, FUL, Proxy Statement, Annual Meeting, Executive Compensation, Corporate Governance, Financial Results, Adjusted EBITDA, EPS, Dividends, Adhesives, Specialty Chemicals, Risk Management, Shareholder Vote
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.